Sep 30, 2026

About this episode:  

For the first time ever, mRNA flu shots are available this respiratory virus season for adults age 50 and older, offering an opportunity to create vaccines better tailored to certain strains of the virus. Moderna's mFLUSIVA was approved by the FDA this summer and is available in some pharmacies. In...

Sep 23, 2026

About this episode:  

Those whose immune systems are more vulnerable due to age, illness, or another condition are at a higher risk of getting sick with and experiencing severe symptoms of seasonal illnesses like flu, COVID-19, and RSV. In this episode: Epidemiologist Caitlin Rivers provides her recommendations for...

Aug 17, 2026

About this episode:  

This summer, Merck & Co. settled more than 200 lawsuits alleging that the company's HPV vaccine, Gardasil, caused cases of autoimmune conditions and fertility issues in young women. But that $50 million settlement is not an admission of fault on the part of the company or the vaccine. In this...

Aug 14, 2026

About this episode:  

In the latest move to alter the childhood vaccine schedule, the president has signed an executive order seeking to scale back and restructure routine immunizations. In this episode: what's in the executive order, what it means, and what comes next.

Guest: 

Dr. Josh Sharfstein is distinguished...

Aug 6, 2026

About this episode:  

In the two decades since the HPV vaccine was approved, women’s risk of developing cervical cancer has dropped by 80% for those vaccinated before age 16 and 66% in those vaccinated after age 16. It has also lowered the risk of other HPV-related cancers in men. In this episode: Journalist Liz Szabo...